Moreover, no significant associations were found between MEF2A and SLC22A3-LPAL2-LPA haplotypes and cardiovascular disease among patients and healthy controls (P ˃ 0.05) (S4 Table in S1 File). Here, MEF2A is linked to cardiovascular disorder.